Deal Process

How an Investment Committee Evaluates a Deal

An investment committee evaluates a deal by testing whether the thesis is clear, the underwriting is supported by evidence, the downside is survivable, and the price and structure compensate for the risks. Committees review a written memo, challenge key assumptions, compare base and downside cases, and approve, decline or approve with conditions.

What is the role of an investment committee?

An investment committee is the group of senior professionals that approves or rejects capital commitments on behalf of a fund, lender or institution. Its role is to provide independent judgment separate from the deal team, which has spent weeks or months working on a transaction and may be anchored to it. The committee checks that each investment fits the mandate, that the risks are understood and priced, that diligence is adequate and that the proposed structure protects the capital being committed. A good committee improves decisions not only by rejecting bad deals but by changing the terms of good ones.

The committee also creates accountability. Recording the thesis, key assumptions and identified risks at approval makes it possible to compare outcomes against expectations later. That feedback loop is how institutions learn which kinds of assumptions tend to prove optimistic and which risks they consistently underestimate, improving future underwriting across the platform. Many institutions formalize this through periodic look back reviews that compare realized results with the original underwriting case. Those reviews are most useful when they examine process as well as results, since a good outcome can follow a weak decision and a sound decision can still lose money.

What belongs in an investment committee memo?

The memo should let a reader understand the deal, the case for doing it and the reasons it could fail, without needing to attend a meeting. It typically opens with a short summary of the transaction, the amount requested and the recommendation. It then sets out the investment thesis in a few specific statements, describes the business or asset, summarizes diligence findings, presents the financial model and scenarios, lists key risks with mitigants, describes the structure and terms, and shows expected returns with sensitivities. For lending committees, the memo also covers repayment sources, collateral, covenants and the risk rating.

Clarity matters more than length. A memo that buries the central risk on page thirty or presents dozens of minor issues alongside two critical ones makes the committee's job harder. Strong memos state the two or three questions on which the outcome really depends and show the evidence the team gathered on each. An executive summary that names those questions on the first page allows committee members to prepare targeted challenges rather than general reactions. Appendices can then hold supporting detail for anyone who wants to check the work behind each conclusion.

• Transaction summary, request and recommendation
• Investment thesis stated as specific, testable claims
• Business or asset description and diligence findings
• Financial model, base case, downside case and sensitivities
• Key risks and mitigants
• Structure, terms, returns and conditions

How does the committee test the thesis and assumptions?

Committee members focus on the assumptions that drive value. They ask where each assumption came from, how it compares with history and with comparable deals, and what evidence would prove it wrong. Common areas of challenge include revenue growth, margin expansion, normalized earnings adjustments, working capital needs, capital spending, exit multiples or cap rates, and the timing of a business plan. The committee looks for assumptions that are individually plausible but collectively optimistic, which is the most common way a model overstates value.

Members also probe the thesis itself. A thesis such as buying a good business at a fair price is not testable. A useful thesis says, for example, that the company can raise prices because of switching costs evidenced by customer retention data, or that a property can achieve higher rents after renovation as shown by comparable renovated buildings. Specific claims allow the committee to judge whether diligence has actually confirmed them. Committees also test whether the deal team has looked for disconfirming evidence, such as former customers, failed competitors or prior owners who struggled with the same plan.

How are downside cases and risks evaluated?

Committees typically spend more time on the downside than the base case. The key question is whether the investment survives a plausible bad outcome without permanent loss of capital, and if not, how large the loss would be. The deal team should present a downside case built on specific adverse events, such as the loss of a major customer, a recession driven volume decline, a cost overrun or a higher exit cap rate, and show the effect on liquidity, covenants and returns. Breakeven analysis, showing how far a key variable can move before capital is impaired, is often more persuasive than a long list of sensitivities.

Risks should be paired with mitigants that actually change the outcome: structural protections such as covenants, collateral and guarantees; pricing that compensates for the risk; or diligence that reduces uncertainty. A mitigant that merely restates the risk, such as noting that management is aware of it, does not count. Committees should also ask what would cause the team to change its view after closing, so that monitoring is focused on the indicators that matter most. Clear early warning signals turn the downside case into an operating tool rather than a one time exercise.

How does the committee weigh returns against risk?

Return expectations should be judged against the risk taken and against the alternatives available to the portfolio. Committees compare expected internal rate of return and multiple of invested capital with hurdle rates set for the strategy, but they also consider the range of outcomes. A deal with a modest base case and limited downside may be more attractive than one with a high base case and a significant chance of losing most of the capital. Some committees ask the team to assign rough probabilities to scenarios and calculate a probability weighted multiple, which forces an explicit view on likelihood rather than presenting only the hoped for case.

Portfolio fit also matters. A good deal may still be declined if it adds too much concentration in a sector, sponsor, geography or risk factor already present in the portfolio, or if it would consume liquidity needed for existing commitments. Committees may also set a maximum hold size or require syndication of part of the position to manage concentration. Those portfolio level decisions are as much a part of the committee's role as the decision on the individual deal, and they should be documented with equal care.

What happens after the committee votes?

The committee may approve, decline or approve with conditions. Conditions commonly include confirmatory diligence items, changes to structure or pricing, tighter covenants, minimum equity contributions or limits on leverage. The deal team must document how each condition was satisfied before closing, and material changes after approval should return to the committee. After closing, the committee or a portfolio review group monitors performance against the underwriting case, revisits risk ratings and decides on follow on investments, amendments or exits. Comparing outcomes with the original memo at regular intervals helps the institution see which parts of its underwriting process are reliable and which need adjustment.

Probability weighted outcome review for a proposed equity investment

1. The deal team proposes a $20,000,000 equity investment. The base case multiple of invested capital is 2.0x, the downside case is 0.9x and the upside case is 3.0x.
2. The committee assigns probabilities of 50% base, 30% downside and 20% upside, which sum to 100%.
3. Probability weighted multiple = (50% x 2.0x) + (30% x 0.9x) + (20% x 3.0x) = 1.00x + 0.27x + 0.60x = 1.87x.
4. In the downside case, the loss is $20,000,000 x (1 - 0.9) = $2,000,000, or 10% of invested capital.
5. If the strategy's guideline is a weighted multiple above 1.75x and a downside loss below 15% of invested capital, the deal passes both tests, and the committee can focus its questions on whether the downside probability is understated.

How underwriters apply this

• State the thesis as two or three specific, testable claims and show the diligence behind each.
• Lead the memo with the risks that determine the outcome rather than an exhaustive list.
• Present a downside case built from named adverse events, plus breakeven analysis on key drivers.
• Pair every risk with a mitigant that changes the outcome through structure, price or diligence.
• Show the range of outcomes and portfolio fit, not just the base case return.
• Track approval conditions to closing and compare results with the memo after closing.

Frequently asked questions

Keep reading

Educational content written by practitioners. Not investment, accounting, legal or tax advice.